Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dieta…
$24.90-0.48%
报价 2026-11-13
市值
$1.68B
EV
$1.55B
PE (TTM)
16.3x
预期 PE (FY2026)
18.6x
52 周区间距高点 -6.2%
$17.02$26.54
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.2x | 1.49 → 1.25(0.8x) | 19.9 |
| FY+32028-12 | 1.2x | 1.49 → 1.44(1.0x) | 17.2 |
毛利率 16% · TTM 收入 $1880M · 基数 EPS 1.49(调整后)
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| HCSGHealthcare Services Group, Inc. | $1.68B | -0.5% | +6.1% | 16.8% | 16.3x | 11.6x | 15.2x | |
| NEOGNeogen Corporation | $2.45B | +0.4% | +3.6% | 47.4% | – | 31.6x | 54.7x | |
| ZBIOZenas BioPharma, Inc. | $1.9B | +1.3% | +13.3% | 0% | – | – | – | |
| KMTSKESTRA MEDICAL TECHNOLOGIES, LTD. | $1.71B | +0.1% | +51.5% | 56.5% | – | – | – | 高增长 |
| CNMDCONMED Corporation | $1.51B | +0.2% | -0.4% | 56.4% | 21.0x | 10.8x | 11.4x | |
| USPHU.S. Physical Therapy, Inc. | $1.49B | +1.0% | +10.1% | 19.6% | 493.9x | 16.3x | 19.9x | GARP |
| NVAXNovavax, Inc. | $1.41B | -2.7% | -55.5% | 77.3% | – | – | – | |
| PNTGThe Pennant Group, Inc. | $1.27B | +0.4% | +27.4% | 13.3% | 35.4x | 23.6x | 50.4x | |
| GDRXGoodRx Holdings, Inc. | $1.21B | +1.4% | +0.6% | 89.5% | 69.4x | 8.7x | 8.5x | |
| 同行中位数 | – | – | +6.8% | 51.9% | 52.4x | 16.3x | 19.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $479.6M | $470.8M | $462.8M | $466.7M | $464.3M | $458.5M | $447.7M | $437.8M |
| Gross Margin | 16.8% | 15.9% | 16.4% | 16.3% | 20.8% | 0.6% | 15.2% | 13.4% |
| Operating Margin | 6.7% | 4.7% | 7.3% | 5.5% | 10.7% | -9.1% | 4.8% | 3.3% |
| Net Income | $24.9M | $22.7M | $26.1M | $31.2M | $43M | $-32.4M | $17.2M | $11.9M |
| Diluted EPS | 0.36 | 0.32 | 0.37 | 0.44 | 0.58 | -0.44 | 0.23 | 0.16 |
| Operating Cash Flow | $30.2M | $24.8M | $43.7M | $17.4M | $71.3M | $28.8M | $27.5M | $36.2M |